Copart, Inc. Reports Q2 2026 Financial Results: Detailed Analysis for Investors

Key Highlights from the Quarterly Report

• Quarterly Period Ended: January 31, 2026
• Exchange & Ticker: Nasdaq Global Select Market, Symbol: CPRT
• Common Stock Outstanding: 963,308,388 shares as of March 2, 2026
• Company Headquarters: 14185 Dallas Parkway, Suite 300, Dallas, TX 75254

Financial Position Overview

Capital Structure

• Preferred Stock: Authorized: 5,000,000 shares, Par Value \$0.0001; No preferred shares issued or outstanding
• Common Stock: Authorized: 1,600,000,000 shares, Par Value \$0.0001; Issued and Outstanding: 963,290,932 (Jan 31, 2026), 967,478,690 (July 31, 2025)
• Accumulated Other Comprehensive Loss: \$(120,283,000)
• Retained Earnings: Not specifically disclosed, but included within equity

Corporate Filings and Compliance

• Copart, Inc. has timely filed all required reports under Section 13 or 15(d) of the Securities Exchange Act of 1934 for the past 12 months and remains subject to ongoing reporting requirements.
• The company has submitted all required Interactive Data Files as per Rule 405 of Regulation S-T in the past 12 months.
• Filer Status: Copart is not a smaller reporting company, non-accelerated filer, or emerging growth company, indicating its large-cap and mature standing.
• Shell Company Status: Copart is not a shell company.

Shareholder Considerations & Price-Sensitive Information

• Robust Balance Sheet: Copart’s strong current asset position (\$6.18B) and significant cash and investments (\$4.79B combined) highlight financial strength and liquidity.
• Low Leverage: With current liabilities at only \$683.3M versus current assets, the company exhibits a conservative financial structure, reducing risk for shareholders.
• Increase in Stockholders’ Equity: From \$9.19B to \$9.79B in six months, indicating value creation and potentially higher intrinsic share value.
• No Preferred Stock Outstanding: Common shareholders face no dilution or preference subordination from preferred equity.
• Large Share Base: 963.3M shares outstanding, making liquidity high and the company eligible for broad index inclusion.
• Accumulated Other Comprehensive Loss: A relatively modest figure in context, but investors should monitor for trends that could affect book value.

Sectional Highlights for Investors

• Financial Statements: The company’s unaudited consolidated balance sheet, statement of income, and cash flow statement are available for detailed review.
• Management Discussion & Analysis (MD&A): The report includes management’s analysis of financial condition and results of operations, liquidity, capital resources, critical accounting policies, and recent accounting standards.
• Risk Factors & Legal Proceedings: The company discloses material risk factors and legal matters that may impact future performance.
• Internal Control Over Financial Reporting: There is an explicit section on disclosure controls and any changes in internal controls, which is crucial for governance-focused investors.
• Market Risk: Quantitative and qualitative disclosures about market risk are included, helping investors assess exposure to financial market volatility.

Potential Price-Moving Insights

• Strong Financial Position: With over \$10.6B in total assets, low debt levels, and a growing equity base, Copart remains well-positioned to invest, repurchase shares, or pay dividends—any such future announcements could impact share value.
• No Evidence of Major Legal or Financial Distress: No disclosures suggest material adverse events, defaults, or significant legal liabilities, which supports shareholder confidence.
• Continued Compliance and Growth: The company is in full compliance with SEC regulations, maintains a large, stable shareholder base, and shows a consistent growth trajectory in equity.

What Should Investors Watch Next?

• Monitor upcoming earnings releases for more granular revenue and profit data (not available in current extract).
• Stay alert to management’s commentary on future capital allocation (buybacks, M&A, dividends).
• Review the MD&A and risk factors for any emerging trends or challenges in Copart’s core markets.
• Watch for any notes on competitive dynamics or regulatory changes, as these can be highly price-sensitive.

Disclaimer: This article is a summary of Copart, Inc.’s SEC filings for the quarterly period ended January 31, 2026. It is for informational purposes only and does not constitute investment advice. Investors should review the full filing and consult with their financial advisor before making any investment decisions.

View COPART INC Historical chart here